Bioray Biotech Co., Ltd (TPEX:7561)

Bioray Biotech Revenue

In the year 2025, Bioray Biotech had annual revenue of 222.73M TWD with 10.42% growth. Bioray Biotech had revenue of 114.14M in the half year ending June 30, 2025, with 21.35% growth.

• Revenue: 222.73M
• Revenue Growth: +10.42%
• P/S Ratio: 2.72
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 606.50M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	222.73M	21.01M	10.42%
Dec 31, 2024	201.71M	9.88M	5.15%
Dec 31, 2023	191.83M	1.23M	0.65%
Dec 31, 2022	190.60M	42.58M	28.77%
Dec 31, 2021	148.02M	-8.28M	-5.30%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 5, 2026

Data Sources Report a data error